If you got a question, look no further.
We post the most common questions
in our FAQ section.
Please fill in the form below to receive a Free Sample of the Report.
"Daiichi Sankyo Company, Ltd : Pharmaceuticals and
Healthcare - Company Profile, SWOT & Financial Report" contains in depth
information and data about the company and its operations. The profile contains
a company overview, key facts, major products and services, swot analysis,
business description, company history, key competitors, financial analysis, key
employees, company locations and subsidiaries as well as employee biographies.
This report is a crucial resource for industry executives and anyone
looking to access key information about "Daiichi Sankyo Company, Ltd".
The report utilizes a wide range of primary and secondary sources, which are
analyzed and presented in a consistent and easily accessible format. ICD
Research strictly follows a standardized research methodology to ensure high
levels of data quality and these characteristics guarantee a unique report.
• Examines and identifies key information and issues about "Daiichi
Sankyo Company, Ltd" for business intelligence requirements.
• Studies and presents the company's strengths, weaknesses, opportunities
(growth potential) and threats (competition). Strategic and operational business
information is objectively reported.
• Provides data on company financial performance.
• The profile also contains information on business operations, company history,
major products and services, key employees, locations and subsidiaries.
Reasons To Buy
• Quickly enhance your understanding of "Daiichi Sankyo Company, Ltd"
• Gain insight into the marketplace and a better understanding of internal and
external factors which could impact the industry.
• Increase business/sales activities by understanding your competitors’
• Recognize potential partnerships and suppliers.
Daiichi Sankyo Company, Ltd (Daiichi Sankyo) is a holding company,
based in Japan. The company is focused on research, development, manufacture and
marketing of pharmaceutical products. The company's business operations are
classified into two divisions: Pharmaceuticals and Others. The company's
Pharmaceuticals division manufactures and markets prescription drug,
over-the-counter (OTC) drugs and quasidrugs. Under Others division, the company
is involved in the real estate leasing, insurance agency business, and provision
for human affairs and accounting services. The pharmaceutical products of the
company are targeted at treating hypertension, hyperlipidemia, diabetes, heart
failure, arrhythmia and heart attack. It also offers functional foods and skin
care products. Outside Japan, Daiichi Sankyo has presence in the Americas,
Europe, and other Asian countries. In Japan, the company has six production
plants, three R&D bases, and 16 branches. It has ten group companies in Japan
that handle different areas of business. Daiichi Sankyo has 107 subsidiaries and
three affiliates. The company is headquartered in Tokyo, Japan.
Table of Contents
1 Business Analysis
1.1 Company Overview
1.2 Business Description
1.3 Major Products and Services
2 Analysis of Key Performance Indicators
2.1 Five Year Snapshot: Overview of Financial and Operational Performance
2.2 Key Financial Performance Indicators
2.2.1 Revenue and Operating Profit
2.2.2 Asset and Liabilities
2.2.3 Net Debt vs. Gearing Ratio
2.2.4 Operational Efficiency
2.3 Key Competitors
3 SWOT Analysis
3.1 SWOT Analysis - Overview
5 Key Employees
6 Key Employee Biographies
7 Locations and Subsidiaries
7.1 Head Office
7.2 Other Locations and Subsidiaries
8.2 Ratio Definitions
List of Tables
Table 1: Major Products and Services
Table 2: Key Ratios - Annual
Table 3: Key Ratios - Interim
Table 4: Key Capital Market Indicators
Table 5: History
Table 6: Key Employees
Table 7: Key Employee Biographies
Table 8: Subsidiaries
List of Figures
Figure 1: Revenue and Operating Profit
Figure 2: Financial Position
Figure 3: Net Debt vs. Gearing Ratio
Figure 4: Operational Efficiency
Figure 5: Solvency
Figure 6: Valuation